Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
+$972M |
| 2 |
Cisco
CSCO
|
+$610M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$572M |
| 4 |
International Flavors & Fragrances
IFF
|
+$492M |
| 5 |
Mastercard
MA
|
+$400M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
DuPont de Nemours
DD
|
+$563M |
| 3 |
Qualcomm
QCOM
|
+$372M |
| 4 |
Merck
MRK
|
+$332M |
| 5 |
Microsoft
MSFT
|
+$305M |
Sector Composition
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.99% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.55% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
MYR Group
MYRG
$2.73B
| $13.2M | ﹤0.01% |
184,227
+1,389
| +0.8% | +$99.5K |
|
1602
Kontoor Brands
KTB
$4.5B
| $13.1M | ﹤0.01% |
270,046
+2,486
| +0.9% | +$121K |
|
1603
AngioDynamics
ANGO
$433M
| $13.1M | ﹤0.01% |
559,944
-3,996
| -0.7% | -$93.5K |
|
1604
Fulton Financial
FULT
$3.54B
| $13.1M | ﹤0.01% |
768,985
-5,568
| -0.7% | -$94.8K |
|
1605
CRISPR Therapeutics
CRSP
$5.12B
| $13.1M | ﹤0.01% |
107,390
+90
| +0.1% | +$11K |
|
1606
MillerKnoll
MLKN
$1.4B
| $13.1M | ﹤0.01% |
317,878
+5,815
| +2% | +$239K |
|
1607
Perdoceo Education
PRDO
$2.26B
| $13.1M | ﹤0.01% |
1,093,077
-33,614
| -3% | -$402K |
|
1608
MSC Industrial Direct
MSM
$5.09B
| $13.1M | ﹤0.01% |
144,944
-5,616
| -4% | -$506K |
|
|
HSKA
1609
DELISTED
Heska Corp
HSKA
| $13.1M | ﹤0.01% |
77,516
+17,059
| +28% | +$2.87M |
|
1610
Codexis
CDXS
$219M
| $13.1M | ﹤0.01% |
570,138
+322,793
| +131% | +$7.39M |
|
1611
CyberArk
CYBR
$23.5B
| $13M | ﹤0.01% |
100,449
+25,675
| +34% | +$3.32M |
|
1612
Eagle Materials
EXP
$7.57B
| $13M | ﹤0.01% |
96,626
-2,699
| -3% | -$363K |
|
1613
Adeia
ADEA
$1.71B
| $13M | ﹤0.01% |
2,253,190
-20,404
| -0.9% | -$118K |
|
1614
LGI Homes
LGIH
$1.39B
| $12.9M | ﹤0.01% |
86,416
-936
| -1% | -$140K |
|
|
BBT
1615
Beacon Financial Corporation
BBT
$2.17B
| $12.9M | ﹤0.01% |
577,461
+33,688
| +6% | +$752K |
|
1616
MacroGenics
MGNX
$100M
| $12.9M | ﹤0.01% |
403,503
-469,718
| -54% | -$15M |
|
1617
Dorman Products
DORM
$4.93B
| $12.8M | ﹤0.01% |
125,077
+144
| +0.1% | +$14.8K |
|
|
RETA
1618
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $12.8M | ﹤0.01% |
128,506
+2,001
| +2% | +$200K |
|
1619
Renasant Corp
RNST
$3.68B
| $12.8M | ﹤0.01% |
308,709
-516,435
| -63% | -$21.4M |
|
1620
Unity
U
$18.4B
| $12.8M | ﹤0.01% |
127,289
-1,126
| -0.9% | -$113K |
|
|
NXGN
1621
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $12.8M | ﹤0.01% |
705,374
-48,959
| -6% | -$886K |
|
|
RVNC
1622
DELISTED
Revance Therapeutics, Inc.
RVNC
| $12.8M | ﹤0.01% |
456,323
-19,826
| -4% | -$554K |
|
|
GRA
1623
DELISTED
W.R. Grace & Co.
GRA
| $12.7M | ﹤0.01% |
212,776
-584,416
| -73% | -$35M |
|
|
FLOW
1624
DELISTED
SPX FLOW, Inc.
FLOW
| $12.7M | ﹤0.01% |
200,103
-3,560
| -2% | -$225K |
|
1625
Avanos Medical
AVNS
$567M
| $12.7M | ﹤0.01% |
289,614
+59,263
| +26% | +$2.59M |
|